I had to drop off.... it seems we are on hold for most items, as we understood, until the S-1/div is complete. Has anyone or could someone ask Joe what pieces of the company are able to move forward in the meantime and how significant this is?
He said Pantheon and Medisource revs had increased "exponentially"... is this from virtually nothing to a little bit? Or is this revenue level now significant?
Is Excellagen generating significant revs? Is there still a hope for the $10MM marketing agreements?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links